Actual Medicinal Product (AMP) - Daklinza 30mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd)
Name Details
| Name | Start Date | End Date | |
|---|---|---|---|
| Name | Current Name Daklinza 30mg tablets | Start Date 03-09-2014 | End Date |
Summary
- Discontinued
- Licensed Route
- Oral
- Availability Restrictions
- Not available
- Licensing Authority
- Medicines - MHRA/EMA
- EMA Indicator
Codes
| BNF | Start Date | End Date |
|---|---|---|
| Previous BNF 05030302 | Start Date 14-01-2015 | End Date 03-04-2022 |
| Code | Start Date | End Date |
|---|---|---|
| 26865411000001101 | 03-09-2014 |
Parent Products
-
VTMDaclatasvir
-
VMPDaclatasvir 30mg tablets
-
AMP(Current) Daklinza 30mg tablets (Bristol...
-
-
Actual Medicinal Product Pack (AMPP) Information
| Pack Size | Indicative Price | Discontinued |
|---|---|---|
| 28 tablet |